Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. EFFECT Other Notice of Effectiveness
  2. SC 13D Stake Beneficial Ownership Report
  3. S-4/A Deal Registration Statement - Business Combination
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. 8-K Event Other events
  7. 425 Deal Prospectus/Communication re Business Combination
  8. S-4 Deal Registration Statement - Business Combination
  9. 8-K Event Other events
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Other events
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 8-K Event Material agreement · Exit or restructuring costs · Change in control · Regulation FD disclosure · Other events
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 10-K/A Report 10-K/A
  18. 8-K Event Delisting notice
  19. 8-K Event Delisting notice
  20. 8-K Event Results of operations

Page 33 of 89 · 1,773 filings